NASDAQ: ZIVO - ZIVO Bioscience, Inc.

Yield per half year: +120%
Sector: Healthcare

Share chart ZIVO Bioscience, Inc.


About

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

More details
Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

EBITDA -0.0084
EV/EBITDA -5.89
IPO date 2012-09-24
ISIN US98978N2009
Industry Personal Care Products
P/BV -5.3
P/S 2211.17
Sector Consumer Staples
Валюта usd
Валюта отчета usd
Выручка 2.0E-5
Сайт https://www.zivobioscience.com
Цена ао 8
Число акций ао 0.0017359 млрд
Change price per day: +7.06% (16.44)
Change price per week: +7.06% (16.44)
Change price per month: +75.82% (10.01)
Change price per 3 month: +107.06% (8.5)
Change price per half year: +120% (8)
Change price per year: +184.79% (6.18)
Change price per 3 year: +410.14% (3.45)
Change price per 5 year: +19 030.43% (0.092)
Change price per 10 year: 0% (17.6)
Change price per year to date: +225.93% (5.4)

Underestimation

Title Value Grade
P/S 82.87 1
P/BV -1.04 0
P/E 0 0
EV/EBITDA -0.3254 0
Total: 2.75

Efficiency

Title Value Grade
ROA, % -1399.49 0
ROE, % 352.57 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0477 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % -89.48 0
Yield Ebitda, % -13.54 0
Yield EPS, % 5.42 1
Total: 1.6

Institutions Volume Share, %
Bartlett & Co. 166 0.01
Bartlett & Co. Wealth Management LLC 166 0.01



Head Job title Payment Year of birth
Mr. John B. Payne President, CEO & Chairman of the Board 400k 1948 (76 years)
Mr. Keith R. Marchiando CFO, Treasurer & Secretary 312k 1962 (62 years)
Dr. Harlan L. Miller III Vice President of Technology & Global Supply N/A

Address: United States, Bloomfield Hills. MI, 21 East Long Lake Road - open in Google maps, open in Yandex maps
Website: https://www.zivobioscience.com